By highlighting the clinical relevance of elevated PPARγ levels in regulating expression of pro-apoptotic CIDEA in glioma, this study warrants further investigation directed towards evaluating efficacy of PPARγ inhibitors as effective anti-glioma therapeutic strategy. Here, PPARG is linked to central nervous system cancer.